Abstract

Acute renal infarction in pediatric patients is a rare oc­cur­rence, usually associated with cardiac anomalies, hyper­coagulable state, diseases with local thrombotic potential, systemic infections, or autoimmune diseases. Following the COVID-19 pandemic, the medical scientific community established diagnostic criteria for PIMS-TS (Pediatric In­flam­matory Multisystem Syndrome – temporally as­so­cia­ted with SARS-CoV-2), also known as multisystem inflamma­to­ry syndrome in children (MIS-C), a condition found in chil­­dren exposed to the new type of coronavirus. Three cli­­ni­­cal phenotypes have been established: toxic shock syn­­drome, Kawasaki-like disease, and undefined in­flam­ma­tory presentation. Cardiovascular manifestations were con­si­dered prominent in all clinical scenarios, while renal and neurologic involvement played a secondary role. There is, however, mounting evidence suggesting that MIS-C is in fact a miscellaneous pathology and that a focus change is war­ranted.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.